Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$27.79 -0.29 (-1.03%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amylyx Pharmaceuticals (AMLX) Return on Capital Employed [ROCE] (2022 - 2026)

Updated

Amylyx Pharmaceuticals (AMLX) recorded Return on Capital Employed [ROCE] of -62.85% in Q2 2026, up 43.22 percentage points from -106.06% a year earlier but down 9.25 percentage points from the prior quarter.

Analysis

Amylyx Pharmaceuticals (AMLX) Return on Capital Employed [ROCE] (2022 - 2026) Analysis & Trends

For FY2025, Amylyx Pharmaceuticals reported Return on Capital Employed [ROCE] of -63.75%, up 32.46 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a three-year change of +35.96 percentage points (FY2022 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -96.21% in FY2024 (-106.63 pp), 10.42% in FY2023 (+110.13 pp) and -99.71% in FY2022.
  • Quarterly Return on Capital Employed [ROCE] has ranged from -162.43% in Q4 2024 to 9.46% in Q4 2023 over the past five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased for four consecutive quarters, with an average year-over-year change of -19.18 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 115.26 percentage points in Q4 2025, against a drop of 171.89 percentage points in Q4 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at -53.60% (Q1 2026), -47.17% (Q4 2025) and -62.22% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Amylyx Pharmaceuticals 3.13 Bn 3.13 Bn - -62.85%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -62.85%
Mar 31, 2026 -53.60%
Dec 31, 2025 -47.17%
Sep 30, 2025 -62.22%
Jun 30, 2025 -106.06%
Mar 31, 2025 -122.09%
Dec 31, 2024 -162.43%
Sep 30, 2024 -114.58%
Jun 30, 2024 -58.33%
Mar 31, 2024 -21.63%
Dec 31, 2023 9.46%
Sep 30, 2023 -1.86%
Jun 30, 2023 -22.12%
Mar 31, 2023 -44.70%
Dec 31, 2022 -83.95%
Sep 30, 2022 -108.42%
Jun 30, 2022 -68.84%
Mar 31, 2022 -72.47%
API Access

Amylyx Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AMLX&period=max&api_key=YOUR_API_KEY